isoproterenol has been researched along with adamantane in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bodor, N; Polgar, P | 1 |
| Choe, E; Ferrara, J; Flint, L; Franklin, E; Grivas, T; Hyman, A; Lippton, H | 1 |
| Ferrara, JJ; Flint, LM; Force, SD; Franklin, EW; Hyman, AL; Lippton, HL; Taheri, PA | 1 |
| Anwar, M; Banister, R; Banister, RE; Feng, C; Feng, CJ; Kadowitz, P; Kadowitz, PJ; Kaye, A; Kaye, AD; Nossaman, B; Nossaman, BD; Turner, K | 1 |
| Ikeda, J; Kimoto, N; Kitayama, T; Kunori, S | 1 |
| Arya, DS; Bhargava, P; Bhatia, J; Kumar, R; Suchal, K | 1 |
6 other study(ies) available for isoproterenol and adamantane
| Article | Year |
|---|---|
Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogs.
Topics: Adamantane; Adrenergic beta-Antagonists; Animals; Dogs; Electrocardiography; Female; Heart; Heart Function Tests; Isoproterenol; Male; Phenylacetates | 1991 |
Femoral vasodilation to cromakalim is blocked by U37883A, a non-sulphonylurea that selectively inhibits KATP channels.
Topics: Adamantane; Analysis of Variance; Animals; Benzopyrans; Cromakalim; Dogs; Drug Interactions; Femur; Injections, Intravenous; Isoproterenol; Morpholines; Nitroglycerin; Potassium Channels; Pyrroles; Regional Blood Flow; Serotonin; Serotonin Receptor Agonists; Vasodilation; Vasodilator Agents | 1995 |
Analysis of regional hemodynamic regulation in response to scald injury.
Topics: Adamantane; Animals; Arginine; Atropine; Blood Pressure; Burns; Diphenhydramine; Dogs; Femoral Artery; Hemodynamics; Hindlimb; Histamine; Isoproterenol; Meclofenamic Acid; Methoxamine; Methysergide; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroglycerin; Pulmonary Circulation; Ranitidine; Regional Blood Flow; Ritanserin; Serotonin; Serotonin Receptor Agonists; Time Factors; Triazines; Ultrasonography; Vascular Resistance; Vasodilation; Verapamil; Xanthines | 1994 |
Responses to propofol in the pulmonary vascular bed of the rat.
Topics: Acetylcholine; Adamantane; Adenosine Triphosphate; Adrenergic beta-Agonists; Anesthetics, Intravenous; Animals; Arachidonic Acid; Arginine; Blood Pressure; Chelating Agents; Cyclooxygenase Inhibitors; Dimethyl Sulfoxide; Diuretics; Dose-Response Relationship, Drug; Edetic Acid; Enzyme Inhibitors; Isoproterenol; Lung; Male; Meclofenamic Acid; Morpholines; Nitric Oxide Synthase; Nitroglycerin; Potassium Channel Blockers; Propofol; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Solvents; Vasodilator Agents | 1999 |
Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats.
Topics: Adamantane; Animals; Diastole; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Heart; Isoproterenol; Male; Myocardium; Rats, Sprague-Dawley; Ventricular Remodeling | 2016 |
Targeting AGE-RAGE signaling pathway by Saxagliptin prevents myocardial injury in isoproterenol challenged diabetic rats.
Topics: Adamantane; Animals; Apoptosis; Diabetes Complications; Diabetes Mellitus, Experimental; Dipeptides; Heart Diseases; Isoproterenol; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Signal Transduction | 2021 |